Bedal raises €10.2m to develop catheter fixation devices

Bedal International NV’s recent funding round of €10.2 million (US$11 million) is “crucial” for the company’s continued growth and development, said Co-CEO Alexander Van Damme. BioWorld“The financing provides the necessary resources to scale operations, enhance product development and expand our market reach, particularly in the competitive US market,” he said.

BioWorld MedTech Financing Scrap Europe